Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...

Choosing one over the other depends on why you need the funds Christina Majaski writes and edits finance, credit cards, and travel content. She has 14+ years of experience with print and digital ...

Note: This virtual cigarette does not represent a particular brand but describes the structure of many of the most popular brands of cigarettes on the market. Only a portion of the tobacco inside a ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.